• Issue

    Neurogastroenterology & Motility: Volume 23, Issue 12

    1051-1139
    December 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

VIEWPOINT

Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets

Pere Clavé, 
  • Pages: 1051-1055
  • First Published: 18 November 2011

REVIEW ARTICLE

Parallel manifestations of neuropathologies in the enteric and central nervous systems

G. Natale,  L. Pasquali,  A. Paparelli,  F. Fornai, 
  • Pages: 1056-1065
  • First Published: 26 September 2011

ORIGINAL ARTICLES

High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain

V. M. Kushnir,  C. Prakash Gyawali, 
  • Pages: 1066-1072
  • First Published: 19 September 2011

G-protein β3 subunit 825CC genotype is associated with postprandial distress syndrome with impaired gastric emptying and with the feeling of hunger in Japanese

M. Shimpuku,  S. Futagami,  T. Kawagoe,  H. Nagoya,  T. Shindo,  A. Horie,  Y. Kodaka,  T. Itoh,  C. Sakamoto, 
  • Pages: 1073-1080
  • First Published: 08 September 2011

Postprandial proximal gastric acid pocket in patients after distal gastrectomy

F. A. M. Herbella,  F. P. P. Vicentine,  L. C. Silva,  M. G. Patti, 
  • Pages: 1081-1083
  • First Published: 21 September 2011

Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders

R. F. Cogliandro,  A. Antonucci,  R. De Giorgio,  G. Barbara,  C. Cremon,  L. Cogliandro,  C. Frisoni,  R. Pezzilli,  A. M. Morselli-Labate,  R. Corinaldesi,  V. Stanghellini, 
  • Pages: 1084-1091
  • First Published: 14 September 2011

Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study

A. Y. Del Valle-Pinero,  A. C. Martino,  T. J. Taylor,  B. L. Majors,  N. S. Patel,  M. M. Heitkemper,  W. A. Henderson, 
  • Pages: 1092-1097
  • First Published: 23 September 2011

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine

K. J. Lee,  N. Y. Kim,  J. K. Kwon,  K. C. Huh,  O. Y. Lee,  J. S. Lee,  S. C. Choi,  C. I. Sohn,  S. J. Myung,  H. J. Park,  M. K. Choi,  Y. T. Bak,  P. L. Rhee, 
  • Pages: 1098-1104
  • First Published: 15 September 2011

Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome

K. Hod,  R. Dickman,  A. Sperber,  S. Melamed,  R. Dekel,  Y. Ron,  Z. Halpern,  S. Berliner,  N. Maharshak, 
  • Pages: 1105-1110
  • First Published: 26 September 2011

Synchronous phosphorylation of CPI-17 and MYPT1 is essential for inducing Ca2+ sensitization in intestinal smooth muscle

D. Mori,  M. Hori,  T. Murata,  T. Ohama,  H. Kishi,  S. Kobayashi,  H. Ozaki, 
  • Pages: 1111-1122
  • First Published: 17 October 2011

Myenteric neural network activated by motilin in the stomach of Suncus murinus (house musk shrew)

A. Mondal,  Y. Kawamoto,  T. Yanaka,  C. Tsutsui,  I. Sakata,  S.-I. Oda,  T. Tanaka,  T. Sakai, 
  • Pages: 1123-1131
  • First Published: 27 October 2011

The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication

P. Bercik,  A. J. Park,  D. Sinclair,  A. Khoshdel,  J. Lu,  X. Huang,  Y. Deng,  P. A. Blennerhassett,  M. Fahnestock,  D. Moine,  B. Berger,  J. D. Huizinga,  W. Kunze,  P. G. McLean,  G. E. Bergonzelli,  S. M. Collins,  E. F. Verdu, 
  • Pages: 1132-1139
  • First Published: 11 October 2011